With this expansion, Epigral's total CPVC resin capacity reaches a remarkable 75,000 TPA, positioning it as the largest CPVC resin facility in the world at a single location.

In addition to the CPVC resin capacity expansion, Epigral is also venturing into CPVC compound production, with a projected capacity of 35,000 TPA. The project is under progress and is expected to be commissioned in the first quarter of the financial year 2025.

CPVC resin and compound are integral components in the manufacturing of CPVC pipes and fittings, renowned for their high heat and chemical resistance properties, thus making them suitable for both domestic and industrial applications.

India's CPVC demand is approximately 2,50,000 tonnes per annum (TPA) and is still developing, with an annual growth expected to range between 10% and 13%.

"Epigral's strategic expansion into this sector demonstrates the company's pledge to innovation and sustainability,” the company said in a statement.

Maulik Patel, CMD of Epigral, said: "I am thrilled to announce the successful commissioning of our 45,000 TPA CPVC Resin plant, which increases our total capacity to 75,000 TPA thus establishing it as the world's largest single-location CPVC resin facility."

Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India. The company is the first to set up an Epichlorohydrin plant in the country and is also the largest capacity plant of CPVC Resin. Epigral is also India’s fourth largest manufacturer of caustic soda, chlorine and hydrogen and a leading manufacturer of caustic potash, chloromethanes and hydrogen peroxide.